The NASDAQ Biotechnology Index (INDEXNASDAQ:NBI) is trading at three year highs despite market volatility, responding to breakthrough innovations and increased deals involving NASDAQ biotech stocks.

Small caps have started holding up better than many large-cap benchmarks, but this is not a blind rush into everything below ...

Both Iovance Biotherapeutics IOVA and Rigel Pharmaceuticals RIGL are small-cap companies focused on the successful commercialization of their marketed products. While Iovance is a cancer biotech ...

If you buy market folklore about January being an indicator for the rest of the year, the start of 2026 bodes well for small-cap stocks. The table is set for a "positive surprise" in small caps, ...

After several years of persistent headwinds, small-cap equities may finally be entering a more supportive phase. Lower interest rates matter disproportionately for small-cap businesses. Compared with ...